120 related articles for article (PubMed ID: 26306824)
1. Learning performances and vulnerability to amyloid toxicity in the butyrylcholinesterase knockout mouse.
Maurice T; Strehaiano M; Siméon N; Bertrand C; Chatonnet A
Behav Brain Res; 2016 Jan; 296():351-360. PubMed ID: 26306824
[TBL] [Abstract][Full Text] [Related]
2. Neuronal seipin knockout facilitates Aβ-induced neuroinflammation and neurotoxicity via reduction of PPARγ in hippocampus of mouse.
Qian Y; Yin J; Hong J; Li G; Zhang B; Liu G; Wan Q; Chen L
J Neuroinflammation; 2016 Jun; 13(1):145. PubMed ID: 27287266
[TBL] [Abstract][Full Text] [Related]
3. Lack of synaptic vesicle protein SV2B protects against amyloid-β₂₅₋₃₅-induced oxidative stress, cholinergic deficit and cognitive impairment in mice.
Detrait E; Maurice T; Hanon E; Leclercq K; Lamberty Y
Behav Brain Res; 2014 Sep; 271():277-85. PubMed ID: 24937053
[TBL] [Abstract][Full Text] [Related]
4. Sigma-1 (σ₁) receptor deficiency reduces β-amyloid(25-35)-induced hippocampal neuronal cell death and cognitive deficits through suppressing phosphorylation of the NMDA receptor NR2B.
Yin J; Sha S; Chen T; Wang C; Hong J; Jie P; Zhou R; Li L; Sokabe M; Chen L
Neuropharmacology; 2015 Feb; 89():215-24. PubMed ID: 25286118
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of cellular prion protein (PrP(C)) prevents cognitive dysfunction and apoptotic neuronal cell death induced by amyloid-β (Aβ₁₋₄₀) administration in mice.
Rial D; Piermartiri TC; Duarte FS; Tasca CI; Walz R; Prediger RD
Neuroscience; 2012 Jul; 215():79-89. PubMed ID: 22537845
[TBL] [Abstract][Full Text] [Related]
6. Knockout of Toll-like receptor 2 attenuates Aβ25-35-induced neurotoxicity in organotypic hippocampal slice cultures.
Suh EC; Jung YJ; Kim YA; Park EM; Lee SJ; Lee KE
Neurochem Int; 2013 Dec; 63(8):818-25. PubMed ID: 24161618
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease like pathology induced six weeks after aggregated amyloid-beta injection in rats: increased oxidative stress and impaired long-term memory with anxiety-like behavior.
Sharma S; Verma S; Kapoor M; Saini A; Nehru B
Neurol Res; 2016 Sep; 38(9):838-50. PubMed ID: 27431920
[TBL] [Abstract][Full Text] [Related]
8. Probucol, a lipid-lowering drug, prevents cognitive and hippocampal synaptic impairments induced by amyloid β peptide in mice.
Santos DB; Peres KC; Ribeiro RP; Colle D; dos Santos AA; Moreira EL; Souza DO; Figueiredo CP; Farina M
Exp Neurol; 2012 Feb; 233(2):767-75. PubMed ID: 22173317
[TBL] [Abstract][Full Text] [Related]
9. Increased amyloid-β peptide-induced memory deficits in phospholipid transfer protein (PLTP) gene knockout mice.
Desrumaux C; Pisoni A; Meunier J; Deckert V; Athias A; Perrier V; Villard V; Lagrost L; Verdier JM; Maurice T
Neuropsychopharmacology; 2013 Apr; 38(5):817-25. PubMed ID: 23303044
[TBL] [Abstract][Full Text] [Related]
10. Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent.
Greig NH; Utsuki T; Ingram DK; Wang Y; Pepeu G; Scali C; Yu QS; Mamczarz J; Holloway HW; Giordano T; Chen D; Furukawa K; Sambamurti K; Brossi A; Lahiri DK
Proc Natl Acad Sci U S A; 2005 Nov; 102(47):17213-8. PubMed ID: 16275899
[TBL] [Abstract][Full Text] [Related]
11. Differential susceptibility following beta-amyloid peptide-(1-40) administration in C57BL/6 and Swiss albino mice: Evidence for a dissociation between cognitive deficits and the glutathione system response.
Prediger RD; Franco JL; Pandolfo P; Medeiros R; Duarte FS; Di Giunta G; Figueiredo CP; Farina M; Calixto JB; Takahashi RN; Dafre AL
Behav Brain Res; 2007 Feb; 177(2):205-13. PubMed ID: 17194489
[TBL] [Abstract][Full Text] [Related]
12. Butyrylcholinesterase-knockout reduces brain deposition of fibrillar β-amyloid in an Alzheimer mouse model.
Reid GA; Darvesh S
Neuroscience; 2015 Jul; 298():424-35. PubMed ID: 25931333
[TBL] [Abstract][Full Text] [Related]
13. Prolonged toxic effects after cocaine challenge in butyrylcholinesterase/plasma carboxylesterase double knockout mice: a model for butyrylcholinesterase-deficient humans.
Duysen EG; Lockridge O
Drug Metab Dispos; 2011 Aug; 39(8):1321-3. PubMed ID: 21540357
[TBL] [Abstract][Full Text] [Related]
14. Hypercholesterolemia accelerates amyloid β-induced cognitive deficits.
Park SH; Kim JH; Choi KH; Jang YJ; Bae SS; Choi BT; Shin HK
Int J Mol Med; 2013 Mar; 31(3):577-82. PubMed ID: 23314909
[TBL] [Abstract][Full Text] [Related]
15. Mice knock out for the histone acetyltransferase p300/CREB binding protein-associated factor develop a resistance to amyloid toxicity.
Duclot F; Meffre J; Jacquet C; Gongora C; Maurice T
Neuroscience; 2010 May; 167(3):850-63. PubMed ID: 20219649
[TBL] [Abstract][Full Text] [Related]
16. Selective activation of α7 nicotinic acetylcholine receptor by PHA-543613 improves Aβ25-35-mediated cognitive deficits in mice.
Sadigh-Eteghad S; Talebi M; Mahmoudi J; Babri S; Shanehbandi D
Neuroscience; 2015 Jul; 298():81-93. PubMed ID: 25881725
[TBL] [Abstract][Full Text] [Related]
17. The anti-amnesic and neuroprotective effects of donepezil against amyloid beta25-35 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor.
Meunier J; Ieni J; Maurice T
Br J Pharmacol; 2006 Dec; 149(8):998-1012. PubMed ID: 17057756
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin prevents β-amyloid(25-35)-impaired neurogenesis in hippocampal dentate gyrus through α7nAChR-dependent cascading PI3K-Akt and increasing BDNF via reduction of farnesyl pyrophosphate.
Wang C; Chen T; Li G; Zhou L; Sha S; Chen L
Neuropharmacology; 2015 Oct; 97():122-32. PubMed ID: 26051402
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
Duysen EG; Li B; Darvesh S; Lockridge O
Toxicology; 2007 Apr; 233(1-3):60-9. PubMed ID: 17194517
[TBL] [Abstract][Full Text] [Related]
20. Riluzole ameliorates learning and memory deficits in Aβ25-35-induced rat model of Alzheimer's disease and is independent of cholinoceptor activation.
Mokhtari Z; Baluchnejadmojarad T; Nikbakht F; Mansouri M; Roghani M
Biomed Pharmacother; 2017 Mar; 87():135-144. PubMed ID: 28049095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
